Nexium (esomeprazole magnesium) (DrugBank: Esomeprazole, Magnesium)
17 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
6 | パーキンソン病 | 0 |
11 | 重症筋無力症 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 0 |
46 | 悪性関節リウマチ | 0 |
51 | 全身性強皮症 | 0 |
64 | 血栓性血小板減少性紫斑病 | 0 |
70 | 広範脊柱管狭窄症 | 0 |
93 | 原発性胆汁性胆管炎[原発性胆汁性肝硬変 (~2017.3)] | 0 |
97 | 潰瘍性大腸炎 | 0 |
166 | 弾性線維性仮性黄色腫 | 0 |
225 | 先天性腎性尿崩症 | 0 |
235 | 副甲状腺機能低下症 | 0 |
284 | ダイアモンド・ブラックファン貧血 | 0 |
291 | ヒルシュスプルング病(全結腸型又は小腸型) | 0 |
296 | 胆道閉鎖症 | 0 |
297 | アラジール症候群 | 0 |
298 | 遺伝性膵炎 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01142128 (ClinicalTrials.gov) | February 2009 | 9/6/2010 | Viokase 16, Viokase16 Plus Nexium and Nexium Alone | A Randomized, Single Site, Double Blind, Fixed Dose, Cross Over Study of Viokase 16, Viokase16 Plus Nexium and Nexium Alone in the Reduction of Abdominal Pain in Patients With Chronic Pancreatitis | Chronic Pancreatitis | Drug: Nexium (esomeprazole magnesium);Drug: Placebo to Nexium;Drug: Viokase 16 (pancrelipase) + Nexium;Drug: Viokase 16 + placebo to Nexium | University of Florida | AstraZeneca | Terminated | 18 Years | 75 Years | All | 12 | Phase 1 | United States |